))
J&J MedTech says new products will fuel growth; FDA clears Exactech ankle surgery navigation
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on October 11, 2024 03:40 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 387929649 series 3481361
Innhold levert av Fast Five by MassDevice. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Fast Five by MassDevice eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, December 6, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Rockley Photonics has begun sampling its biosensing wearable. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the wearable will measure, some of the design components and how optimistic executives are feeling. EndoQuest raised $42 million for its endoluminal robotic technology. Learn what the funds will go toward and what technology EndoQuest is developing. Johnson & Johnson's Ethicon has settled its remaining Physiomesh lawsuits. Whooley goes over what the judge on this case decided, how many cases Ethicon has been dealing with and what its response was to the judge's decision. Exactech won FDA clearance for its new ankle surgery navigation system. Hear what the system is designed for and what doctors think about the system's performance in today's episode. Johnson & Johnson MedTech thinks new products will fuel growth for the company. Whooley and Kirsh discuss where J&J MedTech stands in the medtech market, what the new leader sees for the future of the medtech segment and what will drive value in the future.
…
continue reading
161 episoder
Del
